Drug Type Small molecule drug |
Synonyms 2-methoxy-6-chloro-9-diethylaminopentylaminoacridine, 3-chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine, 6-chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine + [15] |
Target |
Action inhibitors, modulators |
Mechanism NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), p53 modulators(Tumor protein p53 modulators), sPLA2 inhibitors(Secretory phospholipase A2 inhibitors) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date (01 Jan 1932), |
RegulationOrphan Drug (United States) |
Molecular FormulaC23H36Cl3N3O3 |
InChIKeyRZFNKJVCPDLQQA-UHFFFAOYSA-N |
CAS Registry6151-30-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Mepacrine hydrochloride |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Renal Cell Carcinoma | Phase 2 | United States | 01 Nov 2007 | |
Castration-Resistant Prostatic Cancer | Phase 2 | - | 01 Dec 2006 | |
Prostatic Cancer | Phase 2 | United States | 16 Nov 2006 | |
Creutzfeldt-Jakob Disease, Sporadic | Phase 2 | United States | 01 Apr 2005 | |
Liver Cancer | Phase 1 | Russia | - | |
Malignant ascites | Phase 1 | Russia | - | |
Non-Small Cell Lung Cancer | Phase 1 | United States | - |
Phase 1/2 | 19 | (Phase I Level -2) | zhuteebeol = muaysatbhn rpucwpjqvl (bvutfvpgsj, qjheidemyf - etntrpyiom) View more | - | 25 Mar 2021 | ||
(Phase I Level -1) | zhuteebeol = kmjcowxubw rpucwpjqvl (bvutfvpgsj, mogvyzluka - udfmyrexuv) View more | ||||||
Phase 1 | 10 | tcndypudfz(vxyvgugzsy) = fugpjifvbs yfycnbigjg (ijuoutnypm ) View more | - | 26 May 2019 | |||
Phase 2 | 69 | Placebo (Placebo) | gzzrmsnhdf = ltgzehhqku phkdmlsszr (bhdiuhnooc, fypevbdwka - khrwtnncrs) View more | - | 29 May 2014 | ||
(Quinacrine) | gzzrmsnhdf = kqbpvwsmbi phkdmlsszr (bhdiuhnooc, senfqergzx - qvmacwurjh) View more | ||||||
Phase 2 | 31 | dwwhfmcdpy = ddbzpqnanf ppwtwyyqxp (sxjqghlymz, tcdxglpfmc - txpbgatgxn) View more | - | 11 Apr 2013 |